MedPath

Pursuance of Retrospective eGFR study for Strategic Trial for the Prevention of Progression of Overt Diabetic Nephropathy

Not Applicable
Conditions
Diabetes mellitus with/without neprhopathy
Registration Number
JPRN-UMIN000022602
Lead Sponsor
Division of Diabetes, Endocrinology and Metabolism, Department of Internal Medicine, Hyogo College of Medicine
Brief Summary

We clarified the difference of delta-eGFR during a year at the several stage of kidney function in diabetic subjects with nephropathy, from the interim report of Pre-STOPPER study. Delta-eGFR during a year was dramatically dropped worse around the area of kidney failure. Additionally, incremental HbA1c was much related to the deterioration of delta-eGFR during a year.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
10000
Inclusion Criteria

Not provided

Exclusion Criteria

Less than 20 years old.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath